Michal Kicinski

9PUBLICATIONS
125CO-AUTHORS
Gene and molecular therapyPredictive and prognostic markersPacific Peoples life courseHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 03, 2026
Increase in fetal haemoglobin from baseline to day 10 is a biomarker for response to decitabine in AML: Results of the AML21 randomized phase III trial of the EORTC Leukemia Group, Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) and German MDS Study Group.

|Oct 15, 2026
Treatment comparisons using a measurement during follow-up and a right-censored time-to-event outcome.

|Nov 30, 2024
Quality of Life Priorities of Childhood Acute Lymphoblastic Leukemia Survivors Enrolled in EORTC Studies, and a Comparison of Instruments.

Jammbe Musoro, Charlotte Sleurs, Ali Rowsell

|Jun 25, 2024
Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk.

Shunsuke Kimura, Chun Shik Park, Lindsey E Montefiori

|Sep 04, 2023
COLUMBUS-AD: phase III study of adjuvant encorafenib + binimetinib in resected stage IIB/IIC BRAF V600-mutated melanoma.

Alexander Cj van Akkooi, Axel Hauschild, Georgina V Long

|Apr 11, 2023
Work and education interruption in long-term Hodgkin lymphoma survivors: an analysis among patients from nine EORTC-LYSA trials.

Sidsel J Juul, Sára Rossetti, Michal Kicinski

Pageof 2

Frequent Collaborators

2 joint publications

Sidsel Jacobsen Juul

2 joint publications

Sára Rossetti

2 joint publications

Berthe M P Aleman

2 joint publications

Martin Hutchings